Thursday, December 3, 2015

Anti-hypertensive Therapeutics Industry Analysis and Trend in Asia-Pacific Markets to 2021


Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan. This high prevalence is a substantial contributor to healthcare costs and a major cause of morbidity. Browse Full Report With TOC @ http://www.researchmoz.us/anti-hypertensive-therapeutics-in-asia-pacific-markets-to-2021-increasing-prevalence-of-hypertension-drives-market-growth-despite-weak-pipeline-report.html
http://www.researchmoz.us/anti-hypertensive-therapeutics-in-asia-pacific-markets-to-2021-increasing-prevalence-of-hypertension-drives-market-growth-despite-weak-pipeline-report.html

No comments:

Post a Comment